Zobrazit v EDS

New Trends in Vaccine Characterization, Formulations, and Development.

Uloženo v:
Podrobná bibliografie
Název: New Trends in Vaccine Characterization, Formulations, and Development.
Autoři: Kumar, Ravinder
Zdroj: Vaccines; Mar2024, Vol. 12 Issue 3, p338, 3p
Témata: PEPTIDE vaccines, VACCINES, LUMPY skin disease, RIFT Valley fever, HEALTH attitudes
Abstrakt: This document is a list of references cited in various scientific articles related to vaccine development and delivery. The articles cover a wide range of topics, including the use of yeast-based virus-like particles as a platform for vaccine development, trends in COVID-19 vaccine development, and evaluation of a combined live attenuated vaccine for multiple diseases. Other topics include T cell vaccinology, protein subunit vaccines against COVID-19, and the acceptance and attitudes toward COVID-19 vaccines. The document also includes information on the use of yeast as a carrier for drug delivery and vaccine construction, antifungal vaccines, thermostable vaccines, and the global distribution of COVID-19 vaccines. It is important to note that the statements, opinions, and data in the publications are the responsibility of the individual authors and contributors, not the publisher. [Extracted from the article]
Copyright of Vaccines is the property of MDPI and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Databáze: Complementary Index
Popis
Abstrakt:This document is a list of references cited in various scientific articles related to vaccine development and delivery. The articles cover a wide range of topics, including the use of yeast-based virus-like particles as a platform for vaccine development, trends in COVID-19 vaccine development, and evaluation of a combined live attenuated vaccine for multiple diseases. Other topics include T cell vaccinology, protein subunit vaccines against COVID-19, and the acceptance and attitudes toward COVID-19 vaccines. The document also includes information on the use of yeast as a carrier for drug delivery and vaccine construction, antifungal vaccines, thermostable vaccines, and the global distribution of COVID-19 vaccines. It is important to note that the statements, opinions, and data in the publications are the responsibility of the individual authors and contributors, not the publisher. [Extracted from the article]
ISSN:2076393X
DOI:10.3390/vaccines12030338